More actions
Basic information
Display title | Cyberon (drug) |
Default sort key | Cyberon (drug) |
Page length (in bytes) | 10,394 |
Page ID | 284404 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 2 |
Counted as a content page | Yes |
Number of subpages of this page | 1 (0 redirects; 1 non-redirect) |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | OncomingStorm12th (talk | contribs) |
Date of page creation | 16:46, 29 September 2020 |
Latest editor | SV7 (talk | contribs) |
Date of latest edit | 19:03, 3 November 2024 |
Total number of edits | 36 |
Total number of distinct authors | 10 |
Recent number of edits (within past 90 days) | 2 |
Recent number of distinct authors | 2 |
Page properties
Transcluded templates (21) | Templates used on this page:
|
SEO properties
Description | Content |
Article description: (description )This attribute controls the content of the description and og:description elements. | Cyberon was a "praxis-range nootropic" of liquid nanites that had a mind of its own. Although generally referred to as an "it", a patient injected with Cyberon,... |